Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Reexamination Certificate
2008-07-08
2008-07-08
Haddad, Maher M. (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
C424S144100
Reexamination Certificate
active
07396530
ABSTRACT:
The invention provides a method of alleviating a granuloma annulare or a sarcoid disease by administering to a patient having the disease, a therapeutically effective amount of an LFA-1 antagonist.
REFERENCES:
patent: 5002869 (1991-03-01), Schlossman et al.
patent: 5071964 (1991-12-01), Dustin et al.
patent: 5597567 (1997-01-01), Whitcup et al.
patent: 5622700 (1997-04-01), Jardieu et al.
patent: 5730983 (1998-03-01), Wegner et al.
patent: 5932448 (1999-08-01), Tso et al.
patent: 5997867 (1999-12-01), Waldmann et al.
patent: 6037454 (2000-03-01), Jardieu et al.
patent: 6818638 (2004-11-01), Baenteli et al.
patent: 2008368 (1991-06-01), None
patent: 0 346 078 (1989-12-01), None
patent: 0 379 904 (1996-05-01), None
patent: 0 387 668 (1996-12-01), None
patent: WO 90/10652 (1990-09-01), None
patent: WO 90/13281 (1990-11-01), None
patent: WO 90/15076 (1990-12-01), None
patent: WO 91/16927 (1991-11-01), None
patent: WO 91/16928 (1991-11-01), None
patent: WO 91/18011 (1991-11-01), None
patent: WO 93/06864 (1993-04-01), None
patent: WO 93/21953 (1993-11-01), None
patent: WO 98/23761 (1998-06-01), None
patent: WO 98/51343 (1998-11-01), None
Kreuter A et al Failure of etanercept therapy in disseminated granuloma annulare.Arch Dermatol. Sep. 2006;142(9):1236-7; author reply 1237.
Buechner et al., “Identification of T-cell subpopulations in granuloma annulare”Arch Dermatol.119 (2) :125-128 (Feb. 1983).
Campana et al., “Human leukocyte function-associated antigens on lympho-hemopoietic precursor cells”European Journal of Immunology16 (5) :537-542 (May 1986).
Dabski et al., “Generalized granuloma annulare: clinical and laboratory findings in 100 patients”J Am Acad Dermatol.20 (1) :39-47 (Jan. 1989).
Desroches et al., “Regulation and Functional Involvement of Distinct Determinants of Leucocyte Function-Associated Antigen 1 (LFA-1) in T-Cell Activation In Vitro”Scand. J. Immunol.33 :277-286 (1991).
Fekete et al., “Involvement of Lymphocyte Function-Associated Antigen-1 (LFA-1) But Not ICAM-1 in a Radioactive Leukocyte Cell-Mediated Immunity (LA-CMI) Assay”J. Clin. Lab. Immunol.31:145-149 (1990).
Friedman-Birnbaum, “Generalized and localized granuloma annulare”Int J Dermatol.25(6) :364-366 (Jul. 1986).
Hildreth et al., “A Human Lymphocyte-associated Antigen Involved in Cell-mediated Lympholysis”European Journal of Immunology13:202-208 (1983).
Kipnis et al., “Biologic treatments for psoriasis”J Am Acad Dermatol.52(4):671-682 (Apr. 2005).
Modlin et al., “Immunopathologic demonstration of T lymphocyte subpopulations and interleukin 2 in granuloma annulare”Pediatr Dermatol.2(1):26-32 (Jul. 1984).
Muhlbauer et al., “Granuloma annulare”J Am Acad Dermatol.3(3):217-230 (Sep. 1980).
Nishimura et al., “The role of lymphokine-activated cell-associated antigen. III. Inhibition of T-cell activation by monoclonal killer-blocking antibody”Cellular Immunology107(1):32-39 (Jun. 1987).
Sanchez-Madrid et al., “Mapping of antigenic and functional epitopes on the alpha- and beta-subunits of two related mouse glycoproteins involved in cell interactions, LFA-1 and Mac-1”J Exp Med.158(2):586-602 (Aug. 1, 1983).
Smith et al., “Granuloma annulare”Int J Dermatol.36(5):326-333 (May 1997).
Springer et al., “LFA-1 and Lyt-2, 3, molecules associated with T lymphocyte-mediated killing; and Mac-1, an LFA-1 homologue associated with complement receptor function”Immunol. Rev.68:171-195 (1982).
Taylor et al., “The expression of CD18 is increased on Trisomy 21 (Down syndrome) lymphoblastoid cells”Clinical&Experimental Immunology71(2):324-328 (Feb. 1988).
Werther et al., “Humanization of an Anti-Lymphocyte Function-Associated Antigen (LFA) -1 Monoclonal Antibody and Reengineering of the Humanized Antibody for Binding to Rhesus LFA-1”J. of Immunology157:4986-4995 (1996).
Genentech Inc.
Haddad Maher M.
Tan Lee K.
LandOfFree
Method of treating granuloma annulare or sarcoid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating granuloma annulare or sarcoid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating granuloma annulare or sarcoid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2800266